A group of cancer genetics researchers in Italy and the U.S. has retracted three papers in the Journal of Biological Chemistry (JBC) after it became aware they had duplicated some bands in their figures.
Here are the three papers: Continue reading Cancer genetics group retracts three papers for “inappropriate presentation of data”
BioMed Research International has retracted a 2013 paper after it became clear that it was lifted from another 2013 paper about the same subject by some of the same authors.
According to the retraction notice: Continue reading Duplication forces retraction of liver cancer paper
Pfizer has retracted another study involving an experimental cancer drug that later failed later-stage trials.
The study, published in Clinical Cancer Research in 2010, looked at which patients might respond to the drug, called figitumumab. Here’s the notice: Continue reading Pfizer retracts another experimental cancer drug study
Oncology Reviews has retracted a 2014 paper on breast cancer after learning that the authors lifted parts of it from a continuing medical education lesson on Medscape.
The paper, “Challenges of combined everolimus/endocrine therapy in hormone receptor-positive metastatic breast cancer,” was written by Yousif Abubakr, of Thomas Jefferson University in Philadelphia, and Yasar Albushra, of King Faisal Specialist Hospital & Research Centre, in Saudi Arabia.
According to the retraction notice: Continue reading Authors plagiarize CME cancer article, lose their review paper
A group of researchers at Istanbul University has swiftly retracted a paper they published in March in the British Journal of Cancer once it became clear that they were using the wrong antibody.
Here’s the notice for “Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies:” Continue reading Researchers retract breast cancer study after realizing they were using the wrong antibody
A group at the University of Texas Southwestern led by Adi F. Gazdar that found evidence of inappropriate image manipulation in a number of their papers has retracted its seventh and eighth studies.
Here’s the notice for 2005’s “Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection,” in Oncogene: Continue reading UT-Southwestern cancer researchers up to 8 retractions
The Journal of Clinical Investigation is retracting a 2004 paper by a cancer researchers from Italy because of “evident misrepresentation of data and image duplication.”
Here’s the notice for “The IL-12Rβ2 gene functions as a tumor suppressor in human B cell malignancies:” Continue reading JCI retracts 10-year-old cancer study because figures were “intentionally mislabeled”
Bharat Aggarwal, the MD Anderson researcher who has threatened to sue Retraction Watch for writing about issues in his papers, has corrected another study.
Here’s the notice for “Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors:” Continue reading Cancer researcher who threatened to sue Retraction Watch corrects another paper
Robert Getzenberg, a former Hopkins and Pitt cancer researcher, has retracted another paper, his seventh.
Here’s the notice for “Highly specific urine-based marker of bladder cancer,” a paper first published in Urology in 2005: Continue reading Oncology researcher Getzenberg notches seventh retraction
The International Journal of Biochemistry & Cell Biology has retracted a 2013 paper by a group from China after learning that only the first author knew about the article.
The paper was titled “Construction of circular miRNA sponges targeting miR-21 or miR-221 and demonstration of their excellent anticancer effects on malignant melanoma cells,” and it was led by Yuchen Liu. Liu’s affiliations include the Institute of Dermatology and Department of Dermatology at No. 1 Hospital, part of Anhui Medical University, and the State Key Laboratory Incubation Base of Dermatology for the Ministry of National Science and Technology.
Here’s the retraction notice:
Continue reading Forged authorship sinks melanoma paper